These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5868587)

  • 1. Toxicological data of 2-[2-(DI-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748).
    Mulder D; van Eeken CJ
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):371-9. PubMed ID: 5868587
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent.
    Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748).
    Doorenbos HJ; Rekker RF; Nauta WT
    Pharm Weekbl; 1966 Jul; 101(26):565-9. PubMed ID: 5916606
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of xyloxemine hydrochloride, 2-[2-(DI-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride, on reproduction in laboratory animals.
    van Eeken CJ; Mulder D
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):135-41. PubMed ID: 6035090
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicological properties of N,N-dimethyl-4-phenyl-4-(alpha, alpha, alpha-trifluoro-p-tolyl)-3-butenyl-amine hydrochloride (BS 7308).
    van Eeken CJ; Mulder D
    Arch Int Pharmacodyn Ther; 1966 Mar; 160(1):231-40. PubMed ID: 5960124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicological characteristics of the antitussive preparation glaucine].
    Mironova MI; Arzamastsev EV; Bortnikova VV; Krepkova LV
    Farmakol Toksikol; 1983; 46(4):100-3. PubMed ID: 6617832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and toxicological profile of the new antitussive levodropropizine.
    Bestetti A; Giuliani P; Nunziata A; Melillo G; Tonon GC
    Arzneimittelforschung; 1988 Aug; 38(8):1150-5. PubMed ID: 3196409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General toxicology of the new antitussive moguisteine.
    Cavalletti E; Ceserani R; Sala F; Montaguti P; Tognella S
    Arzneimittelforschung; 1994 Nov; 44(11):1227-33. PubMed ID: 7848336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmaco-toxicologic study of Pirexyl, a drug with antitussive activity].
    Tellini N; De Fina V
    Boll Chim Farm; 1970 Aug; 109(8):476-84. PubMed ID: 5502287
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of ethyl dibunate, a new antitussive agent.
    Shemano I; Beiler JM; Hitchens JT
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic and toxicologic studies of m-(1-methyl-3-propyl-3-pyrrolidinyl)phenol (CI-572), an analgetic and antitussive agent.
    Winder CV; Welford M; Wax J; Kaump DH
    J Pharmacol Exp Ther; 1966 Oct; 154(1):161-75. PubMed ID: 4958887
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary pharmacological and toxicological investigation on 2-guaiacolglycolylamino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine: a new bromhexine derivative.
    Testa R; Gelmi G; Canestrini C; Cattaneo A
    Farmaco Prat; 1979 Jun; 34(6):243-54. PubMed ID: 572303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental methods characterizing the toxicomanogenic property of a drug: value of the determination of the habituation threshold].
    La Barre J
    Ann Soc R Sci Med Nat Brux; 1965; 18(1):5-23. PubMed ID: 5893620
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative toxicology of two enantiomers of the peripherally acting non-narcotic antitussive drug moguisteine.
    Cavalletti E; Montaguti P; Sala F; Ceserani R
    Arzneimittelforschung; 1996 Dec; 46(12):1114-9. PubMed ID: 9006784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dropropizine (UCB 1967), an antitussive: oral toxicity study in pure-bred dogs.
    Noel PR
    Arzneimittelforschung; 1969 Aug; 19(8):1246-9. PubMed ID: 5820288
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies in animals on the toxicity of fominoben-HCl].
    Pappritz G; Bauer M; Serbedija R; Ueberberg H
    Arzneimittelforschung; 1974 Nov; 24(11):1816-21. PubMed ID: 4480056
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
    Mäntylä R; Männistö PT; Vuorela A; Nissinen E
    Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Teratological study of a non-narcotic antitussive agent, Asverin].
    Kowa Y
    Boll Chim Farm; 1972 Jan; 111(1):47-51. PubMed ID: 5064101
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statistical study of antitussive synergism in combination of antitussives and expectorants].
    Nakama M; Hayashi G; Kowa Y; Ishii Y; Nakagami S
    Nihon Yakurigaku Zasshi; 1969 Sep; 65(5):446-53. PubMed ID: 5389670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.